These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1009751)

  • 1. [Importance of platelet aggregation in patients with heart valve prostheses].
    Cafiero M; Buono G; Rocca G; Sensale P
    Clin Ter; 1976 Jul; 78(1):35-46. PubMed ID: 1009751
    [No Abstract]   [Full Text] [Related]  

  • 2. Do all patients with mechanical heart valve prostheses need anticoagulant therapy?
    Dale J; Nitter-Hauge S
    Z Kardiol; 1986; 75 Suppl 2():332-7. PubMed ID: 3727714
    [No Abstract]   [Full Text] [Related]  

  • 3. Anticoagulation is necessary in all patients with mechanical prostheses in sinus rhythm.
    Duveau D
    Z Kardiol; 1986; 75 Suppl 2():326-31. PubMed ID: 3727712
    [No Abstract]   [Full Text] [Related]  

  • 4. [Should all prosthetic valve patients be treated by platelet inhibitors?].
    Lévy G; Bordes F; Mariottini P; François G
    Nouv Presse Med; 1976 Jan; 5(5):251-4. PubMed ID: 1264682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invited letter concerning: anticoagulant plus platelet inhibitor therapy in patients with mechanical valve prostheses.
    Stein B; Fuster V
    J Thorac Cardiovasc Surg; 1991 Mar; 101(3):557-9. PubMed ID: 1999952
    [No Abstract]   [Full Text] [Related]  

  • 6. [Oral anticoagulants and antiaggregants in heart valve prostheses].
    Dettori AG; Manotti C
    G Ital Cardiol; 1990 Aug; 20(8):758-65. PubMed ID: 2272425
    [No Abstract]   [Full Text] [Related]  

  • 7. [Anticoagulant and platelet-inhibition therapy of patients with artificial heart valves].
    Boda Z; Voith L; Udvardy M; Hársfalvi J; Pfliegler G; Tornai I
    Orv Hetil; 1987 Feb; 128(5):239-42. PubMed ID: 3547248
    [No Abstract]   [Full Text] [Related]  

  • 8. Preventing thromboembolism in patients with prosthetic heart valves.
    Turpie AG
    Cardiol Clin; 1994 Aug; 12(3):487-93. PubMed ID: 7805081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. eComment: Freedom from complications related to dual ball-and-cage mechanical valve prostheses despite thirty years without anticoagulation.
    Bockeria LA; Skopin II; Kuts EV
    Interact Cardiovasc Thorac Surg; 2008 Dec; 7(6):1169. PubMed ID: 19029395
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antithrombotic therapy in patients with mechanical valve prostheses].
    Roudaut R; Lorient-Roudaut MF
    Arch Mal Coeur Vaiss; 1996 Nov; 89(11 Suppl):1543-50. PubMed ID: 9092416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization of oral anticoagulation for patients with mechanical heart valve prostheses.
    Piper C; Schulte HD; Horstkotte D
    J Heart Valve Dis; 1995 Mar; 4(2):127-37. PubMed ID: 8556172
    [No Abstract]   [Full Text] [Related]  

  • 12. [Anticoagulation in patients with cardiac valve prostheses].
    Paparella D; d'Agostino C; Schinosa Lde L
    Recenti Prog Med; 2004 Apr; 95(4):217-25; quiz 237. PubMed ID: 15147070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pregnancy, heart valve prostheses and anti-platelet aggregation treatment].
    Ben Ismail M; Ghariani M; Jais JM
    Nouv Presse Med; 1975 Mar; 4(10):746 (2). PubMed ID: 1129046
    [No Abstract]   [Full Text] [Related]  

  • 14. [Current clinical results of antiplatelet medication].
    Ordinas A
    Sangre (Barc); 1984; 29(4-C):833-40. PubMed ID: 6393391
    [No Abstract]   [Full Text] [Related]  

  • 15. Discrepancy in guidelines for the prevention of thrombo-embolism in patients with prosthetic heart valves.
    Stefanidis A; Skafidas D; Papasteriadis E
    Eur Heart J; 2007 Oct; 28(20):2552-3; author reply 2553-4. PubMed ID: 17823214
    [No Abstract]   [Full Text] [Related]  

  • 16. Challenges in managing anticoagulant therapy in patients with heart valve prostheses.
    Vink R; Kamphuisen PW; van den Brink RB; Levi M
    Expert Rev Cardiovasc Ther; 2007 May; 5(3):563-70. PubMed ID: 17489678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The anticoagulant treatment of patients with heart valve prostheses].
    Cristodorescu R; Brânzan L; Szvantek C; Drăgulescu S; Anderca I; Streian C
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1989; 41(4):343-52. PubMed ID: 2573944
    [No Abstract]   [Full Text] [Related]  

  • 18. Oral anticoagulation in patients with mechanical valve prostheses: evolving protocols with new generation devices.
    Cotrufo M; De Feo M; De Santo LS; Della Corte A; Scardone M; Costanza S
    Ital Heart J; 2005 May; 6(5):401-4. PubMed ID: 15934413
    [No Abstract]   [Full Text] [Related]  

  • 19. Oral anticoagulation is not necessary for patients with bioprosthetic mitral valve replacement in atrial fibrillation.
    Nuñez L; Pinto AG; Larrea JL; Gil Aguado M; Connor FO
    Z Kardiol; 1986; 75 Suppl 2():321-5. PubMed ID: 3727711
    [No Abstract]   [Full Text] [Related]  

  • 20. [Anticoagulation therapy in patients with valvular prostheses].
    Chlumský J
    Vnitr Lek; 1994 Dec; 40(12):779-82. PubMed ID: 7839632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.